Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00394082
Status:
COMPLETED
Last Update Posted:
2019-11-25
First Post:
2006-10-30
Brief Title:
ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer
Sponsor:
Celgene
Organization:
Celgene
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Metastatic breast cancer Abraxane Bevacizumab | View |